**Chapter 8**

*Vitamin D Deficiency*

[172] Saha S, Chant DC, Welham JL, McGrath JJ. The incidence and prevalence of schizophrenia varies with latitude. Acta Psychiatrica

Scandinavica. 2006;**114**(1):36-39. DOI: 10.1111/j.1600-0447.2005.00742.x

[173] Eyles DW, Trzaskowski M, Vinkhuyzen AAE, Mattheisen M, Meier S, Gooch H, et al. The association between neonatal vitamin D status and risk of schizophrenia. Scientific Reports. 2018;**8**(1):17692. DOI: 10.1038/

[174] Krivoy A, Onn R, Vilner Y, Hochman E, Weizman S, Paz A, et al. Vitamin D supplementation in chronic schizophrenia patients treated with clozapine: A randomized, double-blind. Placebo-controlled Clinical Trial. EBioMedicine. 2017;**26**:138-145. DOI:

10.1016/j.ebiom.2017.11.027

s12888-019-2059-x

Schizophrenia Research. 1997;**26**(2-3):227-233

10.2147/NDT.S176301

[175] Ghaderi A, Banafshe HR,

Mirhosseini N, Moradi M, Karimi MA, Mehrzad F, et al. Clinical and metabolic response to vitamin D plus probiotic in schizophrenia patients. BMC

Psychiatry. 2019;**19**(1):77. DOI: 10.1186/

[177] Asadzadeh Manjili F, Kalantar SM, Arsang-Jang S, Ghafouri-Fard S, Taheri M, Sayad A. Upregulation of vitamin D-related genes in schizophrenic patients. Neuropsychiatric Disease and Treatment. 2018;**14**:2583-2591. DOI:

[176] Naudin J, Capo C, Giusano B, Mege JL, Azorin JM. A differential role for interleukin-6 and tumor necrosis factor-alpha in schizophrenia?

s41598-018-35418-z

**152**
